Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-15-046936)

Filing Details

Accession Number:: 0001104659-15-046936
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-06-23 14:11:11
Reporting Period:: 2015-06-19

Filing Date:: 2015-06-23
Accepted Time:: 2015-06-23 14:11:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1626199	Nivalis Therapeutics Inc.	NVLS	Pharmaceutical Preparations (2834)	208969493

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1645257	L.p. (Cayman) Investors Master Bay Hawkes	C/O Wellington Management Company Llp 280 Congress Street Boston MA 02210		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-06-19	11,700	$14.67	32,100	No	4	P	Direct
Common Stock	Acquisiton	2015-06-22	5,500	$14.75	37,600	No	4	P	Direct
Common Stock	Acquisiton	2015-06-22	283,390	$0.00	320,990	No	4	C	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	C	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series 2 convertible preferred stock	Disposition	2015-06-22	818,714	$0.00	283,390	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct

Footnotes

The Series 2 convertible preferred stock converted into common stock on a 2.889-for-1 basis and had no expiration date.